HYPR — Hyperfine, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1833769 ·
Last close
$0.56
Market Cap
$51.10M
52W High
$1.93
52W Low
$0.54
ADV30
994,300
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 5,960,000 | 3,382,000 | -7,257,000 | -5,981,000 | 57,793,000 | 37,872,000 | 26,049,000 |
| Jun 2026 | 3,904,000 | 1,980,000 | -8,469,000 | -9,298,000 | 62,999,000 | 43,458,000 | 26,241,000 |
| Mar 2026 | 3,903,000 | 1,979,000 | -8,558,000 | -8,623,000 | 60,339,000 | 40,778,000 | 25,978,000 |
| Dec 2025 | 5,293,000 | 2,694,000 | -7,668,000 | -5,912,000 | 55,262,000 | 35,085,000 | 14,257,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-27,566,000
Investing CF
$-356,000
Financing CF
$44,542,000
CapEx
$-356,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.30
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-353,918,000
Inventory
$6,378,000
Receivables
$6,494,000
ST Investments
—
EBIT TTM
$-30,405,000
Pretax Income TTM
$-29,814,000
Interest Exp TTM
$1,165,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$19,060,000
EBITDA
$-30,882,000
Free Cash Flow
$-16,953,124
Enterprise Value
$43,046,140
Total Cash
$37,872,000
Total Debt
$14,087,000
Shares Out
90,993,381
Trailing EPS
$-0.29
Book Value
$0.30
ROE
-101.7%
ROA
-40.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,563,000 | -37,085,000 | -35,574,000 | 55,262,000 | 14,257,000 | 41,005,000 | -27,948,000 |
| Dec 2024 | 12,890,000 | -43,224,000 | -40,720,000 | 58,901,000 | 9,861,000 | 49,040,000 | -38,767,000 |
| Dec 2023 | 11,032,000 | -48,115,000 | -44,238,000 | 94,199,000 | 9,800,000 | 84,399,000 | -41,809,000 |
| Dec 2022 | 6,814,000 | -73,874,000 | -73,164,000 | 134,051,000 | 10,329,000 | 123,722,000 | -72,339,000 |
TTM Snapshot
Revenues TTM
$16,537,000
NetIncome TTM
$-34,852,000
OpCashFlow TTM
—
Assets (Latest)
$62,999,000
Forward EPS
$-0.29
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RNXT | RenovoRx, Inc. | $50.18M | $1.04 | — |
| AURX | Nuo Therapeutics, Inc. | $52.79M | $1.09 | — |
| COCH | Envoy Medical, Inc. | $53.20M | $6.87 | — |
| VASO | VASO Corp | $47.52M | $0.27 | — |
| POSC | POSITRON CORP | $55.84M | $1.70 | — |
News headlines (Yahoo Finance, 1h cache)
Hyperfine (HYPR) Q3 2026 Earnings Call Transcript
2026-11-10 16:29 · Yahoo
Hyperfine, Inc. Q3 2026 Earnings Call Summary
2026-11-10 13:30 · Yahoo
Hyperfine Inc (HYPR) Q3 2026 Earnings Call Highlights: Record Revenue, 73% Growth, and First ...
2026-11-10 07:09 · Yahoo
What Hyperfine (HYPR) Said on Its Q3 Earnings Call
2026-11-10 02:14 · Yahoo
Hyperfine, Inc. Reports Third Quarter 2026 Financial Results
2026-11-09 21:05 · Yahoo
Hyperfine Reports Record Preliminary Q3 Revenue of $6 Million, Up 53% Sequentially
2026-10-08 12:33 · Yahoo
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
2026-10-08 11:30 · Yahoo
MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award
2026-09-16 12:00 · Yahoo
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
2026-09-15 12:15 · Yahoo
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
2026-08-31 12:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.